IMMU-58. REDUCED NEOANTIGEN EXPRESSION AS A POSSIBLE IMMUNE EVASION MECHANISM DURING GLIOMA PROGRESSION

Limited success of immune-based therapies in glioma might be in part due to the lack of enough neoantigens (neoAgs) that can be targeted by immune effector cells. In addition, gliomas also show dynamic clonal evolution over time, possibly leading to immunoediting during progression. In this study, w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Nejo, Takahide, Matushita, Hirokazu, Karasaki, Takahiro, Nomura, Masashi, Nagae, Genta, Takayanagi, Shunsaku, Tanaka, Shota, Takahashi, Satoshi, Kitagawa, Yosuke, Hana, Taijun, Koike, Tsukasa, Narita, Yoshitaka, Nagane, Motoo, Nishikawa, Ryo, Ueki, Keisuke, Aburatani, Hiroyuki, Mukasa, Akitake, Kakimi, Kazuhiro, Saito, Nobuhito
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216610/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.561
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares